APA (7th ed.) Citation

Goldstone, A., Prentice, H., Durrant, J., Franklin, I., Harrison, G., Richards, S., . . . Rowe, J. (2001). Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph plus) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993).

Chicago Style (17th ed.) Citation

Goldstone, A., et al. Allogeneic Transplant (related or Unrelated Donor) Is the Preferred Treatment for Adult Philadelphia Chromosome Positive (Ph Plus) Acute Lymphoblastic Leukaemia (ALL). Results from the International ALL Trial (MRC UKALLXII/ECOG E2993). 2001.

MLA (9th ed.) Citation

Goldstone, A., et al. Allogeneic Transplant (related or Unrelated Donor) Is the Preferred Treatment for Adult Philadelphia Chromosome Positive (Ph Plus) Acute Lymphoblastic Leukaemia (ALL). Results from the International ALL Trial (MRC UKALLXII/ECOG E2993). 2001.